ES2045363T3 - Utilizacion de una composicion dietetica para la inhibicion de la adhesion celular. - Google Patents

Utilizacion de una composicion dietetica para la inhibicion de la adhesion celular.

Info

Publication number
ES2045363T3
ES2045363T3 ES89122506T ES89122506T ES2045363T3 ES 2045363 T3 ES2045363 T3 ES 2045363T3 ES 89122506 T ES89122506 T ES 89122506T ES 89122506 T ES89122506 T ES 89122506T ES 2045363 T3 ES2045363 T3 ES 2045363T3
Authority
ES
Spain
Prior art keywords
inhibition
cellular adhesion
dietary composition
lipid
dietary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89122506T
Other languages
English (en)
Spanish (es)
Inventor
Gayle Crozier-Willi
Mathilde Fleith
Michael Buchanan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Application granted granted Critical
Publication of ES2045363T3 publication Critical patent/ES2045363T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Fodder In General (AREA)
  • Steroid Compounds (AREA)
ES89122506T 1988-12-23 1989-12-06 Utilizacion de una composicion dietetica para la inhibicion de la adhesion celular. Expired - Lifetime ES2045363T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4790/88A CH676909A5 (OSRAM) 1988-12-23 1988-12-23

Publications (1)

Publication Number Publication Date
ES2045363T3 true ES2045363T3 (es) 1994-01-16

Family

ID=4282587

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89122506T Expired - Lifetime ES2045363T3 (es) 1988-12-23 1989-12-06 Utilizacion de una composicion dietetica para la inhibicion de la adhesion celular.

Country Status (14)

Country Link
US (1) US5141958A (OSRAM)
EP (1) EP0374591B1 (OSRAM)
JP (1) JP3284132B2 (OSRAM)
AT (1) ATE81985T1 (OSRAM)
AU (1) AU622500B2 (OSRAM)
CA (1) CA2004332C (OSRAM)
CH (1) CH676909A5 (OSRAM)
DE (1) DE68903378T2 (OSRAM)
ES (1) ES2045363T3 (OSRAM)
IE (1) IE62603B1 (OSRAM)
NO (1) NO895183L (OSRAM)
NZ (1) NZ231938A (OSRAM)
PT (1) PT92690B (OSRAM)
ZA (1) ZA899632B (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994392A (en) * 1988-02-26 1999-11-30 Neuromedica, Inc. Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
JP2782443B2 (ja) * 1988-12-26 1998-07-30 將純 吉原 抗エイズウィルス剤
US5354269A (en) * 1991-12-20 1994-10-11 Fibrogenex, Inc. Method for treating cancer resections
EP0711503A3 (en) * 1994-11-14 1997-11-26 Scotia Holdings Plc Milk fortified with GLA and/or DGLA
US6576636B2 (en) * 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
JP4172726B2 (ja) * 1996-05-22 2008-10-29 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド シス―ドコサヘキサエン酸とドセタキセルとの共有複合体を含有する製剤
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
US7138431B1 (en) 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
US6440448B1 (en) 1998-03-16 2002-08-27 Joseph Intelisano Food supplement/herbal composition for health enhancement
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
WO2000059303A1 (en) * 1999-04-05 2000-10-12 Wake Forest University Oxidized polyunsaturated fatty acids having anti-proliferative activity and methods of use
CA2304906A1 (en) * 2000-04-07 2001-10-07 1411198 Ontario Limited 13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
WO2002076404A2 (en) * 2001-03-23 2002-10-03 Protarga, Inc. Fatty alcohol drug conjugates
JP2005500988A (ja) * 2001-03-23 2005-01-13 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド 脂肪族アミン薬物複合体
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
MX2011012741A (es) * 2009-05-29 2012-05-22 Gibb Holdings Nelson Ltd Un suplemento que comprende grosellas negras o moras grandes.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2490631A1 (fr) * 1980-09-24 1982-03-26 Roussel Uclaf Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique
ATE24266T1 (de) * 1982-04-16 1987-01-15 Nestle Sa Lipidhaltige zusammensetzung fuer die orale, enterale oder parenterale ernaehrung.
EP0093516B1 (en) * 1982-04-29 1986-10-01 Efamol Limited Pharmaceutical composition
CH673223A5 (OSRAM) * 1987-10-16 1990-02-28 Nestle Sa

Also Published As

Publication number Publication date
EP0374591B1 (fr) 1992-11-04
NO895183D0 (no) 1989-12-21
ATE81985T1 (de) 1992-11-15
AU4554789A (en) 1990-06-28
CA2004332C (en) 2000-07-18
AU622500B2 (en) 1992-04-09
PT92690B (pt) 1995-12-29
CH676909A5 (OSRAM) 1991-03-28
DE68903378D1 (de) 1992-12-10
IE62603B1 (en) 1995-02-22
DE68903378T2 (de) 1993-05-06
US5141958A (en) 1992-08-25
CA2004332A1 (en) 1990-06-23
NZ231938A (en) 1992-07-28
NO895183L (no) 1990-06-25
JP3284132B2 (ja) 2002-05-20
EP0374591A1 (fr) 1990-06-27
PT92690A (pt) 1990-06-29
JPH02221228A (ja) 1990-09-04
ZA899632B (en) 1990-09-26
IE893878L (en) 1990-06-23

Similar Documents

Publication Publication Date Title
ES2045363T3 (es) Utilizacion de una composicion dietetica para la inhibicion de la adhesion celular.
ES2019275B3 (es) Metodo para la produccion de una forma de administracion y de dosificacion para farmacos reactivos u otros principios activos.
DE3778699D1 (de) Verwendung von vitamin e zur herstellung von arzneimitteln zur normalisierung der blutgerinnung bei therapie mit hochungesaettigten fettsaeuren vom omega-3-typ.
ES2102367T3 (es) Amidas de acidos isoxazol-4-carboxilicos y amidas de acidos hidroxialquiliden-cianoaceticos, medicamentos que contienen estos compuestos y su utilizacion.
AR221354A1 (es) Procedimiento para la preparacion de nuevos derivados de 2-metoxi-4-amino 5-alquilsulfonil-n-(2-pirrolidil)-metil-benzamida,sus sales de adicion con acidos farmacologicamente aceptables,sus sales de amonio cuaternarias,sus n-oxidos y sus isomeros levogiros y dextrogiros
GB1509979A (en) Pharmaceutical compositions containing aspirin or indomethacin
ATE187887T1 (de) Verzögerte freigabe matrix für arzneimittel
ES2108371T3 (es) Nuevos derivados de estradieno de 11-benzaldoxima, procedimientos para su produccion y farmacos conteniendo estos compuestos.
IT8822399A0 (it) Derivati di monofosforil lipide a e procedimento per la loro preparazione.
ES2033682T3 (es) Procedimiento para preparar una composicion farmaceutica que contiene acido 2-(2-fluoro-4-bifenilil)propionico o una de sus sales.
ATE71288T1 (de) Mischmicell-loesungen mit nichtsteroidalen entzuendungshemmern.
SE8504720D0 (sv) New drug preparation
ATE193440T1 (de) Arzneimittel für insulinresistente diabetiker
MX9207101A (es) Derivados de vitamina d sustituidos con metilo en posicion 20
DE68928993D1 (de) Arzneimittelzubereitung
SG81182A1 (en) New derivatives of non-steroidal anti- flammatory, analgesic and/or antipyretic substances, their use and pharmaceutical formulations containing them
ES2054918T3 (es) Preparacion farmaceutica que se ha de administrar por via oral con una liberacion controlada de las sustancias activas, y un procedimiento para su produccion.
ES2029228T3 (es) Procedimiento para la produccion de un preparado retardado de ibuprofeno.
DK0498841T3 (da) Bioklæbende middel og plaster
AU1099988A (en) 1-(4-hydroxy-3,5-di-tert.-butylbenzoyl) homopiperazine, various derivatives thereof, processes for the preparation of these compounds, medicaments containing them, and their use
IT8920169A0 (it) Derivati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
DK199789D0 (da) Anvendelse af et phenylquinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af et topisk farmaceutisk praeparat til behandling af hud- og/eller slimepithelsygdomme
DE59202227D1 (de) Stabile Salze von 5,10-Methylentetrahydrofolsäure.
MX9303600A (es) Derivados de los acidos fenilpropionico y -cinamico sustituidos por imidazolilo, procedimiento para su obtencion y medicamentos que los contienen.
IT8819958A0 (it) Derivati alchiltiobenzimidazolici attivi farmacologicamente eprocedimento per la loro preparazione.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 374591

Country of ref document: ES